Thromboprophylaxis During Bariatric Surgery
Thromboprophylaxis During Bariatric Surgery
This trial is an assessment of the efficacy of three thromboprophylaxis regimens in two types of bariatric surgery.
- gastric banding and gastric bypass on anti-Xa activity levels
The study includes two groups of 150 patients scheduled for gastric banding or gastric bypass.
Assessment of anti-Xa levels before and 4 hours after the injections from day 0 to 2 in order to determine the best prophylactic regimen allowing expected values ranged between 0.3 and 0.5 IU / ml.
Inclusion Criteria:
Exclusion Criteria:
annick.steib@chru-strasbourg.fr33 3.88.11.54.10
Strasbourg, Alsace, France
BVAILLY@aol.com33 388567300
martine.figier@chru-strasbourg.fr33 388117354
lelia.grunebaum@chru-strasbourg.fr3 3388127528
serge.rohr@chru-strasbourg.fr33 388127223
michel.vix@chru-strasbourg.fr33 388116883
e.junke@chu-nancy.fr33 612163929
thomas.lecompte@chu-nancy.fr33 383851015
i.brunaud@chu-nancy.fr33 3 83858585
karim.asehnoune@chu-nantes.fr00 332 40.08.30.05
pascal.bousquet@chru-strasbourg.fr33 3881176768